Assessing Bladder Radiotherapy Response With Quantitative Diffusion-Weighted Magnetic Resonance Imaging Analysis-Reference-Cited by-同舟云学术

Assessing Bladder Radiotherapy Response With Quantitative Diffusion-Weighted Magnetic Resonance Imaging Analysis

Published:2022-10 Issue:10 Volume:34 Page:630-641
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Hafeez S.^ORCID,Koh M.,Jones K.,El Ghzal A.,D'Arcy J.,Kumar P.,Khoo V.^ORCID,Lalondrelle S.^ORCID,McDonald F.,Thompson A.,Scurr E.,Sohaib A.^ORCID,Huddart R.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference42 articles.

1. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer;James;N Engl J Med,2012

2. Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma;Hoskin;J Clin Oncol,2010

3. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines;Witjes;Eur Urol,2021

4. Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System);Panebianco;Eur Urol,2018

5. Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: systematic review and meta-analysis;Gandhi;BJU Int,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of magnetic resonance imaging for bladder cancer detection following transurethral resection of bladder tumour (TURBT);Abdominal Radiology;2024-05-08

2. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines;European Urology;2024-01

3. Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data System;Nature Reviews Urology;2023-11-30

4. Multiparametric MRI in Era of Artificial Intelligence for Bladder Cancer Therapies;Cancers;2023-11-18

5. Bladder Cancer: New Insights Into Dose, Volume and Prognostic Biomarkers;Clinical Oncology;2022-10